Cannabis Law Report

JULY 8, 2021

cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinical trials. This work will support potential future applications for Investigational New Drugs (INDs) with FDA’s Center for Drug Evaluation and Research (CDER) in humans and animals.

Research and Development 85

Research and Development Pets Cannabinoids Clinical Trials 85

Cannabis Law Report

OCTOBER 15, 2021

RespRx, in addition to its clinical research with COPD, has been engaged in select, non-clinical trials to treat cancer and demonstrated effectiveness. Learn more about USMJ’s ecommerce site at www.usmj.com. In conjunction with PAOG’s ongoing IND initiative for RespRx, and PAOG’s connection with U.S. Billion by 2027.

Treatment 52

Treatment Research and Development CBD eCommerce 52

Cannabis Law Report

SEPTEMBER 8, 2021

Epsilon also owns a number of medicinal cannabis assets, including the Tetra Health clinic, and the Medimar Platform – an end-to-end ecommerce solution for nutraceuticals and cannabis. The facility consists of its own QC lab and grade D cleanroom space for the manufacture of oral dose format products.

Access 97

Access Research and Development Medicine THC 97